Position in ANNX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$8,552,184
+$3,432,793 QoQ
Shares Held
1,497,756
+62.1% QoQ
Ownership
0.733%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#26
of 216 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 90%
Shared 5%
None 6%
Common Shares in ANNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $6,105,781,867 across 230 Biotechnology names. ANNX ranks #88 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,168,956 | $580,655,511 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
1,713,592 | $412,924,262 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
559,687 | $348,987,230 | |
| 4 | INCY |
Incyte Corp
|
2,280,803 | $258,551,825 | |
| 5 | EXEL |
Exelixis, Inc.
|
4,426,620 | $240,852,392 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
4,075,714 | $233,212,353 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
5,230,417 | $185,104,455 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
476,038 | $176,929,041 |
All Filings in ANNX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,552,184 | 1,497,756 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $5,119,391 | 924,078 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $3,607,772 | 718,680 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $2,339,211 | 766,955 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,135,670 | 889,863 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,904,676 | 986,879 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $6,977,187 | 1,360,076 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $6,683,926 | 1,129,042 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $4,030,763 | 822,605 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $2,394,155 | 333,913 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $395,192 | 87,047 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $138,111 | 58,522 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $205,940 | 58,506 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $225,324 | 58,526 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $295,495 | 57,156 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $353,100 | 57,136 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $100,021 | 26,531 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $78,266 | 28,669 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $329,406 | 28,669 | Shares | Defined | 2022-02-09 | |
| No filing history on record for this holder in this stock. | ||||||